Monday, February 26, 2018

Tuesday, 19 September 2017 Divani Caravel Hotel

Conference’s Scope

  • Showcase the current state-of-the-art in the area of oncology and PM and explore research and innovation challenges for advancing the field to the benefit of patients and citizens
  • Look at challenges and drivers for bringing innovative cancer and PM approaches to the market, including how a better understanding of value can drive innovation and what the role of regulators should be
  • Recognize the importance of reimbursement for diagnostics and therapeutics that serve as the foundation of cancer and personalized medicine by working to alleviate confusion and contention between innovators and payers
  • Present new paradigms for targeted therapies, new anti-cancer agents and European drug development initiatives, market access to novel cancer drugs, regulatory issues in marketing authorisation of anti-cancer products, gene and cell therapies and trial endpoints and developing cancer vaccines
  • Encourage innovation by supporting health information technology, evidence generation and patient engagement with the goals of increasing system efficiency and maximizing value for patients
  • Facilitate the move towards a patient centric healthcare model by developing common principles and practices

© 2018 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team